Medical Research News
Focus on the latest clinical studies, reports, findings, programs and standards covering a wide spectrum of medical and health issues. This section highlights research into human populations and includes information about research facilities, funding, resources and public policy.
Shriners Hospitals for Children - Houston and Galveston Partner with Amazing Spaces® for Personal Items Collection
Valentine’s Day themed donation party set for Thursday, February 13 at Amazing Spaces on W. Holcombe Blvd. - January 30, 2014 - Amazing Spaces Storage Centers
ALPCO's New FDA Cleared 25-OH Vitamin D Total ELISA Provides Option for Hospitals and Smaller Clinical Labs to Bring Affordable Testing In-House
ALPCO expands test portfolio for clinical and hospital laboratory customers with the release of a FDA 510(k) cleared 25-OH Vitamin D Total ELISA. - January 22, 2014 - ALPCO
Tourette Syndrome Expert Dr. Jay Tischfield Delivers Keynote Address at Annual New Jersey Conference for the National Alliance on Mental Illness
Dr. Tischfield's 80-minute presentation at the December 14 event centered around his collaboration with the New Jersey Center for Tourette Syndrome & Associated Disorders to form the Cell and DNA Sharing Repository at Rutgers University. - January 11, 2014 - New Jersey Center for Tourette Syndrome
Wake Research Associates Joins Research Study of Pack Pain Device for Those with Failed Back Surgery Syndrome
Failed Back Surgery Syndrome causes discomfort to those whose symptoms persist, despite attempted surgery to correct their pain. Wake Research Associates is currently enrolling volunteers in a study of an already-approved device for the symptoms related to back pain after surgery. To qualify, the... - December 28, 2013 - Wake Research Associates
2013 Marks Incisive Year for Clinical CRO, ICRC-Weyer
An exciting year 2013 has ended for ICRC-Weyer GmbH, a Berlin-based clinical contract research organization. Prof Dr Geerd Weyer, founder of the company reflects upon the highlights of the past year, most notably marked by the company’s 20th year in business. - December 21, 2013 - ICRC-Weyer GmbH
Recent Progress in Neuroscience Research and the New Anti-GABAB1 Receptor Antibody from AbboMax, Inc.
Neurotransmitters are chemical messengers that transmit and modulate signals from neurons to other cells of the brain and body. GABA is the most prevalent inhibitory neurotransmitter in the mammalian central nervous system. GABA receptors are promising drug targets for a wide spectrum of psychiatric and neurological disorders. AbboMax, Inc. offers new anti-GABAB1 receptor polyclonal antibody as well as an extensive collection of neuroscience related antibodies. - December 19, 2013 - AbboMax, Inc.
MiTeGen Announces Online Beamline Guide for Structural Biologists
MiTeGen LLC, a provider of innovative consumables for protein crystallization, crystallography and X-ray diffraction to academic, pharmaceutical, industrial and government researchers around the world, has released an Online Beamline Guide for crystallographers and structural biologists. - December 18, 2013 - MiTeGen, LLC
International Polymer Solutions (IPS) Awarded ISO-9001:2008 Certification
ISO-9001:2008 Quality Certification granted to producer of plastic components for pharmaceutical, semiconductor, laboratory and other environments. International Polymer Solutions (IPS) is proud to announce their recent certification. - December 16, 2013 - International Polymer Solutions Inc.
Just One Conversation Could Change the Course of Tourette Syndrome Research
Individuals and families with TS can participate in the New Jersey Center for Tourette Syndrome & Associated Disorders' genetics sharing program by interviewing with Yale University TS expert Dr. Robert King on January 23-24 and February 7 at Rutgers University or February 8 at Virtua Hospital in Voorhees. - December 13, 2013 - New Jersey Center for Tourette Syndrome
Density Marker Beads Kit Now Available from Cospheric LLC
A new line of density marker beads now offers six different densities including 1.02 g/cc (fluorescent green), 1.04g/cc (fluorescent orange), 1.06g/cc (fluorescent violet), 1.08 g/cc (dark blue), 1.09 g/cc (fluorescent red), and 1.13g/cc (fluorescent blue). Cospheric DMB Density Marker Beads are now provided at a 20% concentration in an aqueous solution in 2.5ml vials. - December 07, 2013 - Cospheric LLC
Global Liver Diseases Therapeutics Market is Expected to Reach USD 10.9 Billion Globally in 2018: Transparency Market Research
Transparency Market Research Report Add "Liver Diseases Therapeutics Market (Chemotherapy, Anti-Virals, Vaccines, Targeted Therapy and Immunosuppressant) - Global Industry Analysis, Size, Share, Trends and Forecast, 2012 - 2018" to its database. - November 28, 2013 - Transparency Market Research
Central Michigan University and NIWH Partner to Study Unique Communication Skills for Physicians and Medical Professionals
In an effort to shift the growing problem of type 2 diabetes (T2DM) and improve doctor-patient communication, Central Michigan University has partnered with the National Institute of Whole Health to study NIWH’s hospital tested Behavioral Engagement with Pure Presence ™ (BEPP). This partnership is the result of doctoral research requirements of CMU’s graduate learner, Christie Clipper, a researcher and administrator in public health. - November 23, 2013 - National Institute of Whole Health
Dr. Misty Brown Receives Honorary Award from Peers
Keller Dentist for nearly two decades receives prestigious award in honor of her dedication to her profession and extraordinary care of her patients. The Peer Reviewed Professionals Cum Laude Organization has nationally recognized Dr. Misty Brown with this esteemed award. Spokesperson for the committee commented, "There is no greater honor than to earn the respect of your peers, Dr. Brown has definitely earned this award." - November 22, 2013 - Dr. Misty Brown
Houston Community Answers the Call to Donate to Shriners Hospital for Children, Amazing Spaces® Storage Center’s Annual Fundraiser
Leader in self storage, Amazing Spaces Storage Centers®, raises funds to benefit the Shriners Hospitals for Children, a world-class hospital system that saves and improves the lives of children regardless of their family's ability to pay. Houston local communities rose to the challenge to donate. - November 22, 2013 - Amazing Spaces Storage Centers
Second Stem Cell Luminary Joins Leading Edge Medical
Second prominent stem cell pioneer joins Hong Kong-based Leading Edge Medical’s (LEMed) Science Advisory Board. - November 20, 2013 - Leading Edge Medical, Ltd.
Phosphorylation: One of the Hottest Topics in Cell Biology Research. Over 140 Phosphospecific Antibodies Are Developed in AbboMax, Inc.
Phosphorylation plays critical roles in the regulation of many cellular processes. This process is tightly associated with protein activity and is a key point of protein function regulation. The new phosphorus group alters the role of the protein: it can activate, deactivate, or cause a change in function. AbboMax, Inc. has developed over 140 phosphospecific antibodies. - November 20, 2013 - AbboMax, Inc.
Three Revolutionary Cancer Technologies to Crowdfund That Will Increase Survival Rates and Emotional Health of Women with Cancer
Recent Breakthroughs in Technology Have Allowed for an Innovative Approach to Increasing Survival Rates and Providing Support for Women with Cancer - November 19, 2013 - Alfred Mann Institute at the University of Southern California
ALPCO Releases STELLUX™ Chemiluminescence Human Total Proinsulin ELISA
A new Human Total Proinsulin ELISA is launched in ALPCO's STELLUX™ Chemiluminescent line of assays. - November 19, 2013 - ALPCO
Pre-Eminent Stem Cell Doctor Joins Leading Edge Medical SAB
Hong Kong-based Leading Edge Medical (LEMed) announces that the world’s number one practicing stem cell doctor has joined its Science Advisory Board. - November 15, 2013 - Leading Edge Medical, Ltd.
Genapsys, Inc. Raises $37M to Commercialize Next Generation Sequencing Platform
GenapSys™, Inc. (GenapSys), a provider of Next Generation Sequencing (NGS) systems, today announced it has raised $37M to commercialize the GENIUS™ 110 system (Gene Electronic Nano-Integrated Ultra-Sensitive), a fully integrated DNA Sequencing system for the rapidly evolving NGS... - November 14, 2013 - Genapsys Inc.
GenWay Biotech Announces Changes to Board of Directors
GenWay Biotech, a leading provider of protein and antibody solutions, today announced the appointment of Thomas Silberg, President and Chief Executive Officer of GenWay Biotech as Chairman of the Board, and Joseph Panetta, President and Chief Executive Officer (CEO) of BIOCOM and Robert Richard Garber, PhD, Drug Development Consultant as members of the Board of Directors. - November 14, 2013 - GenWay Biotech
Tourette Syndrome Families Encouraged to Tell Their Story and Contribute to the Ongoing Search for a Cure
Each month, TS expert Dr. Robert King of the Yale University Child Study Center and TS Clinic in Connecticut comes to Rutgers University in New Jersey to interview families interested in furthering the Tourette research cause. The next time Dr. King will be at Rutgers is December 5 and 6. - November 14, 2013 - New Jersey Center for Tourette Syndrome
Leading Edge Medical and Weber Sign Memorandum of Understanding
Hong Kong-based Leading Edge Medical (LEMed) and Weber Medical have agreed to sign a memorandum of understanding that will form the basis for several joint ventures. - November 09, 2013 - Leading Edge Medical, Ltd.
IonSense, Inc. Presenting Direct Analysis in Real Time (DART®) Mass Spectrometry at the 6th International Symposium on Recent Advances in Food Analysis (RAFA)
IonSense Exhibiting at RAFA, November 5-8, 2013 in Prague, Czech Republic. Customer Workshop Will Feature High Sensitivity Analysis Using Sorbent Technologies Coupled with DART. - November 04, 2013 - IonSense, Inc.
Clinical Trials GPS Launches New Patient Dashboard, Suggests Trials Based on Condition and Location, Connects Research Facilities with Patients in the U.S.
While government health sites remain behind the times, Clinical Trials GPS provides patients with up to date trial and facility data, new patient dashboard and study promotion tools for research sites. - November 03, 2013 - Clinical Trials Institute
MOgene LC Announces the Addition of Illumina HiSeq
MOgene LC, a full service genomics service provider, announces the addition of Illumina HiSeq to further expand its offerings. “MOgene is continually striving to become a one stop shop for genomics services. Expanding our service offerings allows us to partner with our customers and provide... - October 30, 2013 - MOgene, LC
Pipette.com Launches New Blog Solutions.Pipette.com to Help Scientists Find Liquid Handling Answers
Liquid handling experts, Pipette.com has launched their blog site Solutions.Pipette.com. The new site will benefit the Life Science community by making it easier to find the best products and services that fit any lab technician’s problem. These resources include articles, promotions, product... - October 25, 2013 - Pipette.com
New Autism Study Reveals Effectiveness of Web-Based Intervention Tool for Challenging Behaviors
The “Randomized Evaluation of a Web-Based Tool for Designing Function-Based Behavioral Intervention Plans” study, conducted by Center for Autism and Related Disorder’s researchers, is published in the December 2013 journal of Research in Autism Spectrum Disorders. - October 25, 2013 - Center for Autism and Related Disorders
ALPCO Launches STELLUX™ Chemiluminescent Human Insulin ELISA
ALPCO releases second chemiluminescent assay in STELLUX™ product line. - October 24, 2013 - ALPCO
Leading Edge Medical Survey Reflects Keen Interest of Medical Professionals
LEMed survey indicates one third of stem cell doctors are interested in laser-medical therapies for their patients. - October 23, 2013 - Leading Edge Medical, Ltd.
Organomation Announces Laboratory Evaporator Article Series
This fall, Organomation will publish several laboratory evaporator themed pieces to the company's blog. They will focus on critical topics including optimum operating conditions for laboratory evaporators and preventing sample contamination. - October 23, 2013 - Organomation
South Nassau Communities Hospital Surgeon’s Research Published
Their analysis found that TEE-induced esophageal perforation occurred predominantly in the thoracic esophagus segment, in elderly female patients, in an intra-operative setting and in cases with a perceived low risk or an uneventful TEE exam. - October 19, 2013 - Mount Sinai South Nassau
Paid Migraine Clinical Trial Now Enrolling at Achieve Clinical Research Near Birmingham, Alabama; Accepting M/F Patients Suffering from Migraines Age 18 - 75
Achieve is conducting a randomized, single-dose study comparing the efficacy and safety of a combination of acetaminophen and aspirin vs placebo in the acute treatment of migraine headaches. - October 18, 2013 - Clinical Trials Institute
Paid Rheumatoid Arthritis (RA) Clinical Trial Now Enrolling at Achieve Clinical Research in Birmingham, Alabama; Accepting M/F Patients with RA Age 18 - 75
Achieve is conducting a study to evaluate the safety and efficacy of a new drug versus rituximab in patients with moderately to severely active rheumatoid arthritis (RA). - October 16, 2013 - Clinical Trials Institute
KJT Group CEO Interviewed for CEOCFO Magazine
KJT Group Founder and CEO, Kenneth Tomaszewski, is featured in the October 7, 2013 issue of CEOCFO Magazine. - October 11, 2013 - KJT Group
American Clinical Solutions Has Unveiled a New Testing Service for Delta 9-Tetrahydrocannabinol (THC) in Oral Fluid
For patients with a history of chronic marijuana use, detection of urine THC-COOH might not be able to help physicians determine a patient’s current status of marijuana use. - October 10, 2013 - American Clinical Solutions
AsisChem Launches New Streamlined Website with Improved Product Search and E-Commerce Features
AsisChem, the contract medicinal drug and drug discovery and research company co-located in Waltham, Massachusetts and St. Petersburg Russia, announced today the launch of its new website with searchable product profiles and e-commerce shopping functions. The new design of www.asischem.com greatly... - October 08, 2013 - AsisChem
Rosa’s Toufigh Gordi to Present Models and Their Utility in Drug Development at Target Meeting’s 3rd World Drug Discovery Online Conference
Dr. Toufigh Gordi will discuss the application of modeling at different stages in the drug development process, October 16th, 2013. - October 08, 2013 - Rosa & Co LLC
ScienceBased Health’s HydroEye® Benefits Post-Menopausal Dry Eye Sufferers in New Clinical Research
Just Published: One of the Only Controlled Trials to Show Significant Impact on Dry Eye with a Nutritional Product. More than half of peri and post-menopausal women are estimated to suffer from dry eye. Study findings published in the October issue of Cornea show that daily dietary supplementation is effective in improving symptoms and halting progression of dry eye. - October 02, 2013 - ScienceBased Health
Paid COPD Clinical Trial Now Enrolling at Avail Clinical Research Near Orlando, Florida; Accepting M/F Patients with COPD Age 40+
Avail is conducting a 24-week study to evaluate the effect of a once-daily experimental inhalation therapy on arterial stiffness compared to a placebo and another drug in subjects with Chronic Obstructive Pulmonary Disease (COPD). - September 29, 2013 - Clinical Trials Institute
Play an Important Role in Advancing Research and Finding a Cure for Tourette Syndrome at Rutgers University
Individuals and families with Tourette Syndrome can participate in the New Jersey Center for Tourette Syndrome & Associated Disorders' genetics sharing program by interviewing with Dr. Robert King on October 10 or 11 and November 8 at Rutgers. - September 29, 2013 - New Jersey Center for Tourette Syndrome
Multichannel Pipettes Promotion Now Available at Pipette.com
Pipette.com, major distributor of liquid handling products, has announced their extension of promotions on multichannel pipettes. The promotions will help labs increase productivity. - September 26, 2013 - Pipette.com
StemCells21 to Open Second Luxury Medical Center
StemCells21 Company will open its second 5* medical facility. The new addition will feature state-of-the-art operation rooms, Cellular medicine laboratories and compounding nutrition & Hormone laboratories. All of which will be constructed to the highest standards and all class 10,000 clean room grade. - September 22, 2013 - StemCells21
SignaBlok Achieves Key in Vivo Proof of Concept for Treatment of Cancer and Sepsis
Novel First-in-Class Peptide Inhibitor of TREM-1 Modulates the Inflammatory Response and Shows Promise for Treatment of Cancer and Sepsis - September 18, 2013 - SignaBlok, Inc.
Silicon Kinetics® Ramps Commercial Efforts for Affinity Capture-Mass-Spectrometry (AC-MS)
Appoints Jay Smith as CEO and Keith Waddell as VP Business Development - September 12, 2013 - Silicon Kinetics
American Clinical Solutions Releases a New Confirmatory Test for Alcohol Exposure
Alcohol abuse is a serious public health issue in the United States. American Clinical Solutions routinely conducts alcohol tests in urine and oral fluid samples. - September 06, 2013 - American Clinical Solutions
American Clinical Solutions Releases Study "Alprazolam- Used and Abused"
American Clinical Solutions provides testing service for alprazolam and alphahydroxy alprazolam in urine and oral fluid. - September 03, 2013 - American Clinical Solutions
American Clinical Solutions Releases Breakthrough Testing Service for Acetyl Fentanyl
To help combat acetyl fentanyl abuse, American Clinical Solutions is going to offer a UPLC/MS based testing service for acetyl fentanyl in urine and oral fluid. - September 03, 2013 - American Clinical Solutions
Paid Constipation Clinical Trial Now Enrolling at Achieve Clinical Research in Birmingham, AL; Accepting M/F Patients with Opioid-Induced Constipation Age 18-80
Achieve Clinical Research is conducting a randomized clinical study to evaluate the safety, tolerability, and efficacy of a new drug for the treatment of opioid-induced constipation in adults taking opioid therapy for chronic non-cancer pain. - August 31, 2013 - Clinical Trials Institute
Pipette.com Has Extended Their Summer Promotions on Pipettes to Help Alleviate Sequestration Challenges
Pipette.com, major liquid handling products distributor, is extending their summer promotions on pipettes. The extension of these promotions will benefit labs dealing with budget cuts and looking to save money. - August 29, 2013 - Pipette.com